Associate Director, Insulin Access Strategy

Sanofi; Cambridge (MA); On-site; USD 180,000 - 240,000; Full time

Job summary

Sanofi Group is seeking an Associate Director of General Medicines Access Strategy for Insulins, with responsibilities across pricing, contracting, and market access for national payers and institutions. The role requires collaboration across Marketing, HEOR, Legal, and Manufacturing to align strategy with brand goals.

The candidate will lead cross-functional teams, develop value propositions, and provide pricing guidance while staying informed on US payer landscapes and regulatory guidelines.

Qualifications

• BA or BS degree in business administration, finance, or marketing is preferred.
• Advanced degree is favored.
• Minimum 5+ years of business experience in the pharmaceutical, healthcare or biotech sector is a plus.

Responsibilities

• Develop short and long-term access strategies, including pricing and contracting recommendations, value propositions, messaging, and in-depth market research.
• Build comprehensive market access strategies and frameworks integrating payer insights, competitive intelligence, and brand positioning.
• Represent the market access perspective within cross-functional teams including Brand, USMA, HEOR/RWE, Medical, and more.
• Collaborate with Medical and HEOR/RWE teams to inform evidence needs and translate clinical data to value messaging.

Skills

Market access

Payer marketing

Contracting

Financial acumen

Communication skills

Education

Bachelor's degree in business/finance/marketing

Advanced degree

Job description

Sanofi Group is seeking an Associate Director of General Medicines Access Strategy for Insulins, with responsibilities across pricing, contracting, and market access for national payers and institutions. The role requires collaboration across Marketing, HEOR, Legal, and Manufacturing to align strategy with brand goals.

The candidate will lead cross-functional teams, develop value propositions, and provide pricing guidance while staying informed on US payer landscapes and regulatory guidelines.